ATA310177A - Verfahren zur herstellung neuer derivate des 11-desoxy prostaglandins f2 - Google Patents
Verfahren zur herstellung neuer derivate des 11-desoxy prostaglandins f2Info
- Publication number
- ATA310177A ATA310177A AT773101A AT310177A ATA310177A AT A310177 A ATA310177 A AT A310177A AT 773101 A AT773101 A AT 773101A AT 310177 A AT310177 A AT 310177A AT A310177 A ATA310177 A AT A310177A
- Authority
- AT
- Austria
- Prior art keywords
- desoxy
- prostaglandin
- new derivatives
- preparing new
- preparing
- Prior art date
Links
- 229960001342 dinoprost Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- PXGPLTODNUVGFL-YNNPMVKQSA-N prostaglandin F2alpha Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O PXGPLTODNUVGFL-YNNPMVKQSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7612942A FR2349328A1 (fr) | 1976-04-30 | 1976-04-30 | Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments |
FR7701299A FR2377395A2 (fr) | 1977-01-18 | 1977-01-18 | Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA310177A true ATA310177A (de) | 1979-08-15 |
AT355739B AT355739B (de) | 1980-03-25 |
Family
ID=26219428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT310177A AT355739B (de) | 1976-04-30 | 1977-05-02 | Verfahren zur herstellung neuer derivate des 11-desoxy prostaglandins f2 |
Country Status (14)
Country | Link |
---|---|
US (1) | US4119727A (de) |
JP (1) | JPS52148048A (de) |
AR (1) | AR222627A1 (de) |
AT (1) | AT355739B (de) |
AU (1) | AU511408B2 (de) |
CA (1) | CA1100493A (de) |
CH (1) | CH620675A5 (de) |
DE (1) | DE2719244A1 (de) |
DK (1) | DK187677A (de) |
GB (1) | GB1538842A (de) |
IE (1) | IE45141B1 (de) |
LU (1) | LU77240A1 (de) |
NL (1) | NL7704758A (de) |
SE (1) | SE436037B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0282901U (de) * | 1988-12-12 | 1990-06-27 | ||
US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
US20050203081A1 (en) * | 2004-02-25 | 2005-09-15 | Jinbo Lee | Inhibitors of protein tyrosine phosphatase 1B |
US7521473B2 (en) | 2004-02-25 | 2009-04-21 | Wyeth | Inhibitors of protein tyrosine phosphatase 1B |
US7906552B2 (en) | 2004-08-10 | 2011-03-15 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US7183310B2 (en) | 2004-08-10 | 2007-02-27 | Allergan, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US7101904B2 (en) * | 2004-08-10 | 2006-09-05 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
AU2006205029B2 (en) * | 2005-01-14 | 2012-09-06 | Allergan, Inc. | Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
TW201410248A (zh) * | 2005-03-04 | 2014-03-16 | Sucampo Ag | 處理週邊血管疾患之方法及組成物 |
AU2006311942B2 (en) | 2005-11-03 | 2012-11-22 | Allergan, Inc. | Prostaglandins and analogues as agents for lowering intraocular pressure |
CA2724271A1 (en) * | 2008-05-15 | 2009-11-19 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
EP2923756B1 (de) | 2012-11-26 | 2018-05-30 | Braskem S.A. | Durch hybridstütze geträgerter metallocenkatalysator, verfahren zur herstellung davon, polymerisationsverfahren zur herstellung eines ethylenhomopolymers oder copolymers mit breiter oder bimodaler molmassenverteilung, verwednung des geträgerter metallocenkatalysators und ethylenpolymer mit breiter oder bimodaler molmassenverteilung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3776940A (en) * | 1966-08-09 | 1973-12-04 | G Just | Intermediates for producing prostaglandins |
US3956284A (en) * | 1972-07-13 | 1976-05-11 | Pfizer Inc. | Heterocyclic 15-substituted-ω-pentanorprostoglandins |
US3794664A (en) * | 1972-08-17 | 1974-02-26 | G Just | Bicyclo(3.1.0)hexane intermediates for producing prostaglandins f1alpha and f1beta |
US4387241A (en) * | 1974-11-01 | 1983-06-07 | American Cyanamid Company | Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives |
-
1977
- 1977-04-21 SE SE7704616A patent/SE436037B/xx not_active IP Right Cessation
- 1977-04-29 DK DK187677A patent/DK187677A/da not_active Application Discontinuation
- 1977-04-29 NL NL7704758A patent/NL7704758A/xx not_active Application Discontinuation
- 1977-04-29 GB GB18082/77A patent/GB1538842A/en not_active Expired
- 1977-04-29 CH CH541177A patent/CH620675A5/fr not_active IP Right Cessation
- 1977-04-29 DE DE19772719244 patent/DE2719244A1/de active Granted
- 1977-04-29 AR AR267416A patent/AR222627A1/es active
- 1977-04-29 CA CA277,423A patent/CA1100493A/fr not_active Expired
- 1977-04-30 JP JP5061277A patent/JPS52148048A/ja active Granted
- 1977-05-02 US US05/792,563 patent/US4119727A/en not_active Expired - Lifetime
- 1977-05-02 IE IE885/77A patent/IE45141B1/en unknown
- 1977-05-02 AT AT310177A patent/AT355739B/de not_active IP Right Cessation
- 1977-05-02 AU AU24795/77A patent/AU511408B2/en not_active Expired
- 1977-05-03 LU LU77240A patent/LU77240A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AT355739B (de) | 1980-03-25 |
DE2719244A1 (de) | 1977-11-17 |
IE45141L (en) | 1977-10-30 |
AU2479577A (en) | 1978-11-09 |
DE2719244C2 (de) | 1987-10-15 |
DK187677A (da) | 1977-10-31 |
NL7704758A (nl) | 1977-11-01 |
CH620675A5 (de) | 1980-12-15 |
IE45141B1 (en) | 1982-06-30 |
SE436037B (sv) | 1984-11-05 |
JPS6131103B2 (de) | 1986-07-17 |
AR222627A1 (es) | 1981-06-15 |
CA1100493A (fr) | 1981-05-05 |
GB1538842A (en) | 1979-01-24 |
US4119727A (en) | 1978-10-10 |
LU77240A1 (de) | 1977-12-13 |
AU511408B2 (en) | 1980-08-21 |
SE7704616L (sv) | 1977-10-31 |
JPS52148048A (en) | 1977-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DD132869A5 (de) | Verfahren zur herstellung neuer aminothiazolylazetamido-derivate | |
DD122972A5 (de) | Verfahren zur herstellung neuer derivate der 3-chinolinkarbonsaeure | |
ATA310177A (de) | Verfahren zur herstellung neuer derivate des 11-desoxy prostaglandins f2 | |
PT68044A (de) | Verfahren zur herstellung neuer derivate des alkylendiami | |
ATA185776A (de) | Verfahren zur herstellung neuer thiocarbamid-derivate | |
AT370109B (de) | Verfahren zur herstellung neuer acetylenderivate des androst-4-ens | |
DD131020A5 (de) | Verfahren zur herstellung neuer derivate von 3-alkyl-1,9-dihydroxy-und-1-hydroxy-9-keto-dibenzo(b,d)-pyranen | |
AT368520B (de) | Verfahren zur herstellung neuer azetylenderivate des androst-4-ens | |
DD134351A5 (de) | Verfahren zur herstellung neuer pyridobenzodiazepinonen | |
PT72140A (de) | Verfahren zur herstellung neuer derivate des 2-amino-aethanols | |
AT365601B (de) | Verfahren zur herstellung neuer derivate von 4- | |
ATA845475A (de) | Verfahren zur herstellung neuer prostaglandin- analoge | |
AT363933B (de) | Verfahren zur herstellung neuer derivate des(1, 3)-benzodioxins | |
AT355028B (de) | Verfahren zur herstellung neuer salze des 1,3- bis-(beta-aethylhexyl)-5-amino-5-methyl- hexahydropyrimidins | |
AT357276B (de) | Verfahren zur herstellung des prostaglandins a2 und bestimmter derivate desselben | |
DD128852A5 (de) | Verfahren zur herstellung neuer d-homosteroide | |
ATA783078A (de) | Verfahren zur hertellung neuer derivate des eburnamenins | |
DD128774A5 (de) | Verfahren zur herstellung neuer quartaerer derivate von sandwicin | |
AT363622B (de) | Verfahren zur herstellung neuer derivate des pregn-4-ens | |
ATA713578A (de) | Verfahren zur herstellung neuer derivate der 4-cyclohexyl-1-naphthalinessigsaeure | |
DD124252A5 (de) | Verfahren zur herstellung neuer adenosinnitrate | |
DD132348A5 (de) | Verfahren zur herstellung neuer derivate des 9-chlorprednisolons | |
ATA142378A (de) | Verfahren zur herstellung neuer derivate des n- phosphonomethylglycins | |
AT343111B (de) | Verfahren zur herstellung neuer phenylbutazonderivate | |
ATA23077A (de) | Verfahren zur herstellung neuer derivate des amino-3-hydroxy-2-phenoxy-1-propans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee | ||
ELJ | Ceased due to non-payment of the annual fee |